What does the evidence say about Aged Garlic Extract Cardiovascular Markers Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Aged Garlic Extract Cardiovascular Markers Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Furthermore, gut dysbiosis has been associated with increased inflammatory status and risk of cardiovascular events. [Ried K (2018); evidence level 4] - Results: Mean blood pressure was significantly reduced by 10 ± 3.6 mmHg systolic and 5.4 ± 2.3 mmHg diastolic compared to placebo. [Ried K (2018); evidence level 4] - Background: Previous research suggests Kyolic-aged-garlic-extract to be effective in reducing blood pressure in a large proportion of hypertensive patients similar to first-line standard antihypertensive medication. [Ried K (2018); evidence level 4] - High blood pressure has been linked to gut dysbiosis, with a significant decrease in microbial richness and diversity in hypertensives compared to normotensives. [Ried K (2018); evidence level 4] - Our trial is the first to assess the effect of aged garlic extract on central blood pressure and arterial stiffness, regarded as important risk factors for cardiovascular morbidity. [Ried K (2016); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.